JP2010526840A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526840A5
JP2010526840A5 JP2010507811A JP2010507811A JP2010526840A5 JP 2010526840 A5 JP2010526840 A5 JP 2010526840A5 JP 2010507811 A JP2010507811 A JP 2010507811A JP 2010507811 A JP2010507811 A JP 2010507811A JP 2010526840 A5 JP2010526840 A5 JP 2010526840A5
Authority
JP
Japan
Prior art keywords
proportions
mixtures
compound according
treatment
pharmaceutically usable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010507811A
Other languages
English (en)
Japanese (ja)
Other versions
JP5543335B2 (ja
JP2010526840A (ja
Filing date
Publication date
Priority claimed from DE102007022565A external-priority patent/DE102007022565A1/de
Application filed filed Critical
Publication of JP2010526840A publication Critical patent/JP2010526840A/ja
Publication of JP2010526840A5 publication Critical patent/JP2010526840A5/ja
Application granted granted Critical
Publication of JP5543335B2 publication Critical patent/JP5543335B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010507811A 2007-05-14 2008-04-18 複素環式インダゾール誘導体 Expired - Fee Related JP5543335B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007022565A DE102007022565A1 (de) 2007-05-14 2007-05-14 Heterocyclische Indazolderivate
DE102007022565.4 2007-05-14
PCT/EP2008/003143 WO2008138448A2 (de) 2007-05-14 2008-04-18 Heterocyclische indazolderivate

Publications (3)

Publication Number Publication Date
JP2010526840A JP2010526840A (ja) 2010-08-05
JP2010526840A5 true JP2010526840A5 (cg-RX-API-DMAC7.html) 2011-06-02
JP5543335B2 JP5543335B2 (ja) 2014-07-09

Family

ID=39837777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010507811A Expired - Fee Related JP5543335B2 (ja) 2007-05-14 2008-04-18 複素環式インダゾール誘導体

Country Status (10)

Country Link
US (1) US8334309B2 (cg-RX-API-DMAC7.html)
EP (1) EP2155728B1 (cg-RX-API-DMAC7.html)
JP (1) JP5543335B2 (cg-RX-API-DMAC7.html)
AR (1) AR066557A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008250706B2 (cg-RX-API-DMAC7.html)
CA (1) CA2687162C (cg-RX-API-DMAC7.html)
DE (1) DE102007022565A1 (cg-RX-API-DMAC7.html)
ES (1) ES2548444T3 (cg-RX-API-DMAC7.html)
IL (1) IL202034A (cg-RX-API-DMAC7.html)
WO (1) WO2008138448A2 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2012135631A1 (en) 2011-03-30 2012-10-04 Arrien Pharmaeuticals Llc Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
WO2012173099A1 (ja) * 2011-06-14 2012-12-20 塩野義製薬株式会社 血管内皮リパーゼ阻害活性を有するアミノ誘導体
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP3024456A4 (en) 2013-07-26 2017-04-12 Update Pharma Inc. Combinatorial methods to improve the therapeutic benefit of bisantrene
JP2018506571A (ja) 2015-02-27 2018-03-08 リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ Ｒｈｏ関連プロテインキナーゼの阻害及び疾患の治療のためのインダゾリルチアジアゾールアミン及び関連する化合物
EP3504204A4 (en) 2016-08-26 2020-05-27 Lycera Corporation INDAZOLYL-L, 2,4-THIADIAZOLAMINES AND RELATED COMPOUNDS FOR THE INHIBITION OF RHO ASSOCIATED PROTEIN KINASE AND THE TREATMENT OF DISEASE
GB201801226D0 (en) * 2018-01-25 2018-03-14 Redx Pharma Plc Modulators of Rho-associated protein kinase
WO2021043966A1 (en) * 2019-09-06 2021-03-11 Inflazome Limited Nlrp3 inhibitors
CN111548320B (zh) * 2019-10-09 2023-03-24 贵州大学 一类1，3，4-噁二唑酰肼类化合物及其制备方法和应用
GB202200735D0 (en) * 2022-01-20 2022-03-09 Redx Pharma Plc Compounds

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227841A (en) 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
DE19917990A1 (de) 1999-04-20 2000-11-02 Florian Lang Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
DE10042137A1 (de) 2000-08-28 2002-03-14 Florian Lang sgk2 und sgk3 als diagnostische und therapeutische Targets
US7115617B2 (en) * 2001-08-22 2006-10-03 Amgen Inc. Amino-substituted pyrimidinyl derivatives and methods of use
AU2002353186A1 (en) 2001-12-19 2003-06-30 Smithkline Beecham P.L.C. (1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
FR2836915B1 (fr) * 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
BR0311291A (pt) 2002-05-17 2005-03-29 Pharmacia Italia Spa Derivados de aminoindazol ativos como inibidores da cinase, processo para sua preparação e composições farmacêuticas compreendendo os mesmos
FR2844267B1 (fr) 2002-09-05 2008-02-15 Aventis Pharma Sa Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
KR101166745B1 (ko) 2002-09-05 2012-07-23 아방티 파르마 소시에테 아노님 의약으로서의 신규한 아미노인다졸 유도체 및 이를 함유하는 약제학적 조성물
AU2003293376A1 (en) 2002-12-10 2004-06-30 Imclone Systems Incorporated Anti-angiogenic compounds and their use in cancer treatment
FR2848554A1 (fr) 2002-12-12 2004-06-18 Aventis Pharma Sa Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
BR0316606A (pt) 2002-12-12 2005-10-11 Aventis Pharma Sa Derivados de aminoindazóis e sua utilização como inibidores de quinases
US20050019366A1 (en) 2002-12-31 2005-01-27 Zeldis Jerome B. Drug-coated stents and methods of use therefor
WO2005000813A1 (en) 2003-05-30 2005-01-06 Imclone Systems Incorporated Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors
US20050090529A1 (en) 2003-07-31 2005-04-28 Pfizer Inc 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
JP4895811B2 (ja) 2003-09-11 2012-03-14 ケミア，インコーポレイテッド サイトカイン阻害剤
TWI344961B (en) 2003-10-15 2011-07-11 Ube Industries Novel indazole derivative
WO2005051308A2 (en) 2003-11-19 2005-06-09 Signal Pharmaceuticals, Llc Methods of treating diseases and disorders by targeting multiple kinases
EP1692128A1 (en) * 2003-11-19 2006-08-23 Signal Pharmaceuticals LLC Indazole compounds and methods of use thereof as protein kinase inhibitors
TW200524601A (en) 2003-12-05 2005-08-01 Bristol Myers Squibb Co Heterocyclic anti-migraine agents
DE102004028862A1 (de) * 2004-06-15 2005-12-29 Merck Patent Gmbh 3-Aminoindazole
CN101389335A (zh) 2004-10-18 2009-03-18 安姆根有限公司 噻二唑化合物和使用方法
JP2008534633A (ja) * 2005-04-04 2008-08-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング Ｃｈｋ１、ｃｈｋ２およびｓｇｋ阻害剤としてのインダゾールスクアリン酸誘導体
DE102007002717A1 (de) * 2007-01-18 2008-07-24 Merck Patent Gmbh Heterocyclische Indazolderivate

Similar Documents

Publication Publication Date Title
JP2010526840A5 (cg-RX-API-DMAC7.html)
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
SG155961A1 (en) Pyrazoles as 11-beta-hsd-1
WO2007060140A3 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
JP2016512825A5 (cg-RX-API-DMAC7.html)
UA110853C2 (uk) Лікарські форми інгібітора гістондеацетилази у комбінації з бендамустином та їхнє застосування
JP2012533546A5 (cg-RX-API-DMAC7.html)
JP2006504795A5 (cg-RX-API-DMAC7.html)
RU2012123372A (ru) Гетероциклические модуляторы транспортеров атф-связывающей кассеты
WO2020113213A3 (en) Cyclic pantetheine derivatives and uses thereof
NO20074872L (no) Pyrazoler
ATE442349T1 (de) Diacylglycerol-acyltransferase-hemmer
EA201000702A1 (ru) Некоторые производные 2-пиразинона и их применение в качестве ингибиторов нейтрофильной эластазы
CN103717571B8 (zh) 9‑氨基甲基取代的四环素类化合物
JP2010520246A5 (cg-RX-API-DMAC7.html)
JP2017222722A5 (cg-RX-API-DMAC7.html)
JP2017522300A5 (cg-RX-API-DMAC7.html)
JP2006518731A5 (cg-RX-API-DMAC7.html)
CN115605485A (zh) 大环化合物的固体形式及其制备和用途
JP2020529995A5 (cg-RX-API-DMAC7.html)
NO20065880L (no) 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor
JP2009517411A5 (cg-RX-API-DMAC7.html)
JP2009518415A5 (cg-RX-API-DMAC7.html)
CA2596145A1 (en) Prevention and treatment of thromboembolic disorders